论文部分内容阅读
本杂志1999年第5卷第1期曾刊出我写的“复发与转移——原发性肝癌研究的一个重点”述评,两年多过去,这一领域又有新进展。如前所述,在肝癌的各种治疗方法中,仍以手术切除的疗效最好。5年生存率:小肝癌切除可达50%～60%,大肝癌切除约为30%,不能切除肝癌的缩小后切除也达40%～60%。我所415例生存5年以上的病人中,396例(95.4%)曾进行一期或二期手术切除。说明手术切除在我所获得肝癌长期生存病人中的作用。但根
In the first issue of Volume 5 of 1999, this magazine published a review of “Recurrence and metastasis—a key point in the study of primary liver cancer” written by me. Over two years later, there have been new developments in this field. As mentioned earlier, surgical resection is the best among the various treatments for liver cancer. 5-year survival rate: Resection of small hepatocellular carcinoma can reach 50% to 60%, removal of large hepatocellular carcinoma is about 30%, and reduction of resection of unresectable hepatocellular carcinoma can reach 40% to 60%. Of the 415 patients who survived more than 5 years, 396 (95.4%) had undergone primary or secondary surgical resection. Explain the role of surgical resection in patients with long-term survival of liver cancer. But root